“Final Frontier:” Moderna Begins Testing Experimental Covid Jab on Infants as Young as 6 Months Old
Biotechnology company Moderna Therapeutics has officially begun large-scale testing of its experimental COVID-19 vaccine on America’s youngest children.
As of “late October,” Moderna’s clinical trial – dubbed KidCOVE – kicked off phase III, which tests the controversial mRNA vaccine technology on children between the ages of 6 months and 5 years old. It will be conducted across 79 locations in 13 states and involve about ~13,250 participants in total.
Phases I and II of the trial, which tested on 12-17-year-olds and 5-11-year-olds – respectively, were completed over the past several months.
Now, researchers are turning to toddlers and infants to carry out their experiments – and keep in mind,
